Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections
- 1 November 1997
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 16 (11) , 789-796
- https://doi.org/10.1007/bf01700407
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patientsJournal of Antimicrobial Chemotherapy, 1996
- Meropenem Versus Tobramycin Plus Clindamycin for Treatment of Intraabdominal Infections: Results of a Prospective, Randomized, Double-Blind Clinical TrialClinical Infectious Diseases, 1995
- Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Meropenem Meningitis Study GroupAntimicrobial Agents and Chemotherapy, 1995
- Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in ratsAntimicrobial Agents and Chemotherapy, 1995
- Stability of meropenem and effect of 1 beta-methyl substitution on its stability in the presence of renal dehydropeptidase IAntimicrobial Agents and Chemotherapy, 1992
- Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy malesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Meropenem: evidence of lack of proconvulsive tendency in miceJournal of Antimicrobial Chemotherapy, 1989
- Factors predisposing to seizures in seriously III infected patients receiving antibiotics: Experience with imipenem/cilastatinThe American Journal of Medicine, 1988
- APACHE IICritical Care Medicine, 1985
- Carbapenems, a new class of beta-lactam antibioticsThe American Journal of Medicine, 1985